Association of HLA class II DRB1, DPA1 and DPB1 polymorphism with genetic susceptibility to idiopathic dilated cardiomyopathy in Chinese Han nationality

References

• Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation 2001; 104(9)1076–1082
   PubMed Web of Science ®Google Scholar
• Caforio AL, Mahon NJ, Tona F, Mckenna WJ. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: Pathogenetic and clinical significance. Eur J Heart Fail 2002; 4(4)411–417
   Google Scholar
• Caforio AL, Bonifacio E, Keeling PJ, Grazzini M, Schiaffino S, Bottazzo GF, McKenna WJ. Idiopathic dilated cardiomyopathy: A persistent viral infection or an organ-specific autoimmune disease? The trial of 2 major pathogenetic hypotheses. G Ital Cardiol 1992; 22(1)63–72, Review
   Google Scholar
• Caforio AL, Bauce B, Boffa GM, De Cian F, Angelini A, Melacini P, Razzolini R, Fasoli G, Chioin R, Schiaffino S, Thiene G, Volta DS. Autoimmunity in myocarditis and dilated cardiomyopathy: Cardiac autoantibody frequency and clinical correlates in a patient series from Italy. G Ital Cardiol 1997; 27(2)106–112
   Google Scholar
• Carlquist JF, Ward RH, Husebye D, Feolo M, Anderson JL. Major histocompatibility complex class II gene frequencies by serologic and deoxyribonucleic acid genomic typing in idiopathic dilated cardiomyopathy. Am J Cardiol 1994; 74(9)918–920
   Google Scholar
• De Leeuw N, Melchers WJ, Ruiter DJ, Caforio AL, Balk AH, de Jonge N, Galama JM. Autoimmune markers are undetectable in end stage idiopathic dilated cardiomyopathy. Clin Pathol 1999; 52(10)739–743
   Google Scholar
• Luppi P, Rudert W, Licata A, Riboni S, Betters D, Cotrufo M, Frati G, Condorelli G, Trucco M. Expansion of specific alphabeta+T-cell subsets in the myocardium of patients with myocarditis and idiopathic dilated cardiomyopathy associated with Coxsackievirus B infection. Hum Immunol 2003; 64(2)194–210
   Google Scholar
• Sigusch HH, Lehmann MH, Schnittler U, Reinhardt D, Figulla HR. Tumour necrosis factor-alpha expression in idiopathic dilated cardiomyopathy: Correlation to myocardial inflammatory activity. Cytokine 2000; 12(8)1261–1266
   Google Scholar
• De Leeuw N, Ruiter DJ, Balk AH, de Jonge N, Melchers WJ, Galama JM. Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy. Transpl Int 2001; 14(5)299–306
   Google Scholar
• Osa A, Almenar L, Palencia M, Puig N, Chirivella M, Montora J. Antigens of the major histocompatibility system in ischemic heart disease and idiopathic dilated cardiomyopathy. Clin Cardiol 1999; 22(4)292–296
   Google Scholar
• Imagawa A, Hanafusa T, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Maruyama T, Makino H. Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia 2005; 48(2)294–300
   Google Scholar
• Fukazawa T, Kikuchi S, Niino M, Yabe I, Miyagishi R, Fukaura H, Hamad T, Tashiro K. Susceptibility genes for multiple sclerosis. Nippon Rinsho 2003; 61(8)1311–1316, Review
   Google Scholar
• Azizah MR, Ainoi SS, Kuak SH, Kong NC, Normaznah Y, Rahim MN. The association of the HLA class II antigens with clinical and autoantibody expression in Malaysian Chinese patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol 2001; 19(2)93–100
   Google Scholar
• Reveille JD. Genetic studies in the rheumatic diseases: Present status and implications for the future. J Rheumatol Suppl 2005; 72: 10–13, Review
   PubMedGoogle Scholar
• Liu W, Li WM, Sun NL. Relationship between HLA-DQA1 polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy. Chin Med J (Engl) 2004; 117(10)1449–1452
   Google Scholar
• McKenna CJ, Codd MB, McCann HA, Sugrue DD. Idiopathic dilated cardiomyopathy: Familial prevalence and HLA distribution. Heart 1997; 77(6)549–552
   Google Scholar
• Liu W, Li WM, Sun NL. HLA-DQA1 gene polymorphism in idiopathic dilated cardiomyopathy. Chin J Cardiol (Chin) 2002; 30(8)477–479
   Google Scholar
• Carlquist JF, Menlove RL, Murray MB, O'Connell JB, Anderson JL. HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies. Circulation 1991; 83(2)515–522
   Google Scholar
• Ibisch C, Gallot G, Vivien R, Diez E, Jotereau F, Garand R, Vie H. Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: A perspective for adjuvant immunotherapy post-bone marrow transplantation. Bone Marrow Transplant 1999; 23(11)1153–1159
   Google Scholar
• Sawyer RT, Parsons CE, Fontenot AP, Maier LA, Gillespie MM, Gottschall EB, Silveira L, Newman LS. Beryllium-induced tumor necrosis factor-alpha production by CD4+ T cells is mediated by HLA-DP. Am J Respir Cell Mol Biol 2004; 31(1)122–130
   Google Scholar
• Liu W, Li WM, Sun NL. HLA-DQA1, -DQB1 polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy in Hans of northern China. Ann Hum Genet 2005; 69(4)382–388
   Google Scholar
• Martinetti M, Salvaneschi L, Graziano G, Arbustini E, Diegoli M, Dondi E, Pizzochero C, Gavazzi A. HLA polymorphism in the susceptibility or resistance to dilated cardiomyopathy. G Ital Cardiol 1992; 22(1)73–83
   Google Scholar
• Caforio AL, Martinetti M, Schwarz G, Bonifacio E, Gavazzi A, Graziano G, Lorini R, Cuccia M, McKenna WJ, Bottazzo GF. Idiopathic dilated cardiomyopathy: Lack of association between circulating organ-specific cardiac antibodies and HLA-DR antigens. Tissue Antigens 1992; 39(5)236–240
   Google Scholar
• Hiroi S, Harada H, Nishi H, Satoh M, Nagai R, Kimura A. Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese. Biochem Biophys Res Commun 1999; 261(2)332–339
   PubMed Web of Science ®Google Scholar
• Wang Q, Liao Y, Gong F, Mao H, Zhang J. HLA-DRB1 gene polymorphism in patients with dilated cardiomyopathy. J Tongji Med Univ 2000; 20(2)141–142
   Google Scholar
• Wang Q, Liao Y, Gong F, Mao H, Zhang J. Possible association of HLA-DRB1 gene with the autoantibody against myocardial mitochondria ADP/ATP carrier in dilated cardiomyopathy. J Huazhong Univ Sci Technolog Med Sci 2002; 22(3)231–232
   Google Scholar